George Papatheodoridis
National and Kapodistrian University of Athens
H-index: 90
Europe-Greece
Top articles of George Papatheodoridis
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Machine learning approaches to enhance diagnosis and staging of patients with MASLD using routinely available clinical information | Plos one | Matthew McTeer Douglas Applegate Peter Mesenbrink Vlad Ratziu Jörn M Schattenberg | 2024/2/29 |
Thyroid function, adipokines and mitokines in metabolic dysfunction‐associated steatohepatitis: A multi‐centre biopsy‐based observational study | Liver International | Matina Kouvari Laura Valenzuela‐Vallejo Evangelos Axarloglou Ornella Verrastro Georgios Papatheodoridis | 2024/1/23 |
HBV DNA and HBsAg levels at 24 weeks off-treatment predict clinical relapse and HBsAg loss in HBeAg-negative patients who discontinued antiviral therapy | Gastroenterology | Milan J Sonneveld Shao-Ming Chiu Jun Yong Park Sylvia M Brakenhoff Apichat Kaewdech | 2024/1/1 |
Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictions | Alison D Marshall Alex R Willing Abe Kairouz Evan B Cunningham Alice Wheeler | 2024/2/14 | |
Alteration of small intestinal occludin and ZO-1 expession in liver cirrhosis. | Pathology International | Theodoros Voulgaris Dina Tiniakos Dimitrios Karagiannakis Despoina Myoteri Despoina Karandrea | 2024/1/22 |
Efficacy of Newer Nucleos (t) ide Analogs After Hepatitis B Immunoglobulin Discontinuation Against Hepatitis B and D Recurrence in Liver Transplant Recipients | Transplantation | Evangelos Cholongitas Theodora Oikonomou Konstantina Bafa Emmanouil Sinakos George V Papatheodoridis | 2024/4/1 |
PAGE-B incorporating moderate HBV DNA levels predicts risk of HCC among patients entering into HBeAg-positive chronic hepatitis B | Journal of Hepatology | Ho Soo Chun George V Papatheodoridis Minjong Lee Hye Ah Lee Yeong Hwa Kim | 2024/1/1 |
Virological and clinical outcomes of patients with HDV-related compensated cirrhosis treated with Bulevirtide monotherapy for 96 weeks: a retrospective multicenter european … | Elisabetta Degasperi Maria Paola Anolli Victor de Lédinghen Sophie Metivier Mathias Jachs | 2023/6/1 | |
High levels of all-cause mortality among people who inject drugs from 2018 to 2022 | International Journal of Drug Policy | Sotirios Roussos Theodoros Angelopoulos Evangelos Cholongitas Spyridon Savvanis Nikolaos Papadopoulos | 2024/4/1 |
The Diagnostic Yield of Upper GI Endoscopy in Patients Iron Deficiency Anemia and/or Chronic Diarrhea | Journal of Gastroenterology & Digestive Systems | T Voulgaris M Tampaki E Laoudi P Karatzas G Karamanolis | 2024/1/3 |
Five‐year follow‐up of 96 weeks peginterferon plus tenofovir disoproxil fumarate in hepatitis D | Liver International | Olympia E Anastasiou Florin A Caruntu Manuela G Curescu Kendal Yalcin Ulus S Akarca | 2024/1 |
Bulevirtide monotherapy prevents liver decompensation and reduces mortality in patients with HDV-related cirrhosis: a case control study with propensity score weighted analysis | Digestive and Liver Disease | E Degasperi A De Silvestri MP Anolli D Sambarino M Borghi | 2024/2/1 |
The effect of propranolol on gastrointestinal motility and permeability in patients with cirrhosis and significant portal hypertension | Elias Xirouchakis Hariklia Kranidioti Emilia Hadziyanni Anastasia Kourikou Christos Reppas | 2024/3/29 | |
Successful therapy with tenofovir disoproxil fumarate (TDF) in patients with chronic hepatitis B (CHB) does not guarantee amelioration of liver damage assessing by transient … | BMC gastroenterology | Hariklia Kranidioti Konstantinos Zisimopoulos Theodora Oikonomou Theodoros Voulgaris Spyros Siakavellas | 2024 |
Sodium–glucose linked transporter 2 inhibitors in liver cirrhosis: Beyond their antidiabetic use | Christos Siafarikas Chris J Kapelios Margarita Papatheodoridi John Vlachogiannakos Nikolaos Tentolouris | 2024/1/31 | |
Isolated nonspecific terminal ileitis: prevalence, clinical evolution and correlation with metachronous diagnosis of Crohn’s disease: a retrospective study and review of the … | Evgenia Koureta Pantelis Karatzas Maria Tampaki Theodoros Voulgaris Efrosini Laoudi | 2024/3 | |
P804 Does Crohn's disease extent and behavior have an impact on ustekinumab effectiveness? A real-world multicenter retrospective study | Journal of Crohn's and Colitis | N Samarentsis C Kapizioni N Georgakopoulou G Michalopoulos A Striki | 2024/1/1 |
Low HBV DNA and HBsAg levels at 24 weeks off-treatment predict sustained response and HBsAg loss in patients who discontinued antiviral therapy | Age (median, years) | MJ Sonneveld SM Chiu JY Park SM Brakenhoff A Kaewdech | 2023/6/1 |
Mo1517 CLINICALLY SIGNIFICANT PRURITUS IN PATIENTS WITH CHRONIC LIVER DISEASE (CLD): DATA FROM THE GLOBAL LIVER REGISTRY™(GLR™) | Gastroenterology | Zobair M Younossi Marlen Castellanos Fernandez Yusuf Yilmaz Ming-Lung Yu Mohamed El-Kassas | 2023/5/1 |
Hepatocellular carcinoma: The virus or the liver? | Alkistis Papatheodoridi George Papatheodoridis | 2023/8 |
Co-Authors
